IGC Pharma, Inc.
IGC
$0.3262
$0.01986.46%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 470.00K | 1.55M | 1.82M | 1.20M | 1.38M |
Total Receivables | 92.00K | 88.00K | 79.00K | 91.00K | 108.00K |
Inventory | 1.43M | 1.51M | 1.51M | 1.54M | 1.93M |
Prepaid Expenses | 304.00K | 198.00K | 240.00K | 115.00K | 97.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 752.00K | 908.00K | 754.00K | 761.00K | 75.00K |
Total Current Assets | 3.05M | 4.25M | 4.41M | 3.71M | 3.58M |
|
|||||
Total Current Assets | 3.05M | 4.25M | 4.41M | 3.71M | 3.58M |
Net Property, Plant & Equipment | 3.48M | 3.63M | 3.78M | 3.89M | 5.50M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 1.87M | 1.80M | 1.72M | 1.62M | 1.18M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 681.00K | 687.00K | 688.00K | 688.00K | 999.00K |
Total Assets | 9.08M | 10.37M | 10.59M | 9.90M | 11.26M |
|
|||||
Total Accounts Payable | 835.00K | 768.00K | 771.00K | 773.00K | 648.00K |
Total Accrued Expenses | 981.00K | 1.11M | 1.17M | 1.02M | 995.00K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 124.00K | 134.00K | 133.00K | 124.00K | 127.00K |
Total Finance Division Other Current Liabilities | 717.00K | 794.00K | 417.00K | 419.00K | 166.00K |
Total Other Current Liabilities | 717.00K | 794.00K | 417.00K | 419.00K | 166.00K |
Total Current Liabilities | 2.66M | 2.80M | 2.49M | 2.34M | 1.94M |
|
|||||
Total Current Liabilities | 2.66M | 2.80M | 2.49M | 2.34M | 1.94M |
Long-Term Debt | 134.00K | 135.00K | 136.00K | 137.00K | 138.00K |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 12.00K | 35.00K | 69.00K | 84.00K | 115.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 16.00K | 20.00K | 20.00K | 20.00K | 17.00K |
Total Liabilities | 2.82M | 2.99M | 2.71M | 2.58M | 2.21M |
|
|||||
Common Stock & APIC | 129.31M | 128.58M | 127.35M | 124.41M | 123.26M |
Retained Earnings | -119.59M | -117.76M | -116.04M | -113.67M | -110.78M |
Treasury Stock & Other | -3.46M | -3.44M | -3.43M | -3.42M | -3.43M |
Total Common Equity | 6.26M | 7.38M | 7.88M | 7.32M | 9.05M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 6.26M | 7.38M | 7.88M | 7.32M | 9.05M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 6.26M | 7.38M | 7.88M | 7.32M | 9.05M |
|